J.P. Morgan + SpaceX= Largest IPO
Congratulations to the @SpaceX team on this milestone, we were proud to serve as a lead bookrunner on the transaction.
🌍 Europe’s edge: World class clinicians, academic research, and innovation are creating a vibrant startup ecosystem. Across EMEA, there’s meaningful investor interest ready to support the next wave of growth.
🔗 Integration is key: Winning models will consolidate wearables and clinical tools into single, trusted systems. Partnerships with tech giants are emerging.
🔄 Anticipated public and private M&A is picking up pace: Year to date, deal volume and value in biopharma are already tracking ahead of last year, and we are also seeing momentum build across healthcare more broadly, including medical devices, life sciences tools & diagnostics,
💼 Capital returns, but with higher standards: A reopening of the public markets is characterized by more diligent investors focused on clinical validation and differentiation, clear value creation, and experienced management.
🏥 Healthcare innovation accelerates: AI is reshaping drug development at all stages. While the emphasis has largely been on drug discovery and preclinical development to date, the most significant short term opportunity may lie in AI integration at the clinical stage, including
🌐 AI is moving from hype to measurable impact. Productivity gains are picking up momentum, and companies that are putting AI into their day to day infrastructure are expected to see stronger net profit margins.
📈 Resilience is the new normal: Despite geopolitical noise, markets are projected to finish strong in 2026, supported by a strong overall economy, buoyed by consumer confidence and earnings growth.
This week’s European Healthcare Symposium brought together industry leaders, innovators, and investors to explore the future of healthcare across the continent and beyond. The conversations were rich, the perspectives global, and the focus clear: resilience, quality, and
Fan spend is not one-size-fits-all. Explore how shopper mix and location strategy can impact outcomes for hotels, merchandise, dining and beyond. spr.ly/6014B80fir
"How should money move next?" Our Head of Innovation Economy EMEA, Veronique Steiner, joined J.P. Morgan colleagues, industry experts, banks, fintechs, and merchants at this year’s Money20/20 in Amsterdam. Take a look at some of the standout moments as she takes us behind the